A crossover intervention trial to evaluate the impact of rapid on-admission screening in preventing MRSA infection in surgery.
Completed
- Conditions
- MRSA control in surgery.
- Registration Number
- NL-OMON22295
- Lead Sponsor
- SPCI / HUG
- Brief Summary
In preparation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20000
Inclusion Criteria
All patients admitted to the surgical department for >24 hours.
Exclusion Criteria
Ambulatory surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of patients with nosocomial MRSA infection acquired in surgery, expressed as incidence per 1000 patient-days
- Secondary Outcome Measures
Name Time Method 1. Nosocomial MRSA acquisition rate (expressed as the rate of new MRSA cases detected by any type of clinical isolate in previously MRSA-free patients per 1000 patient-days);<br /> <br>2. The rate of surgical site infections (per 100 procedures) and other site-specific infections caused by MRSA.